Clinical Performance of the Checkable Medical At-Home Strep A Test

The Checkable Medical At-Home Strep A Test is a rapid chromatographic immunoassay for the qualitative detection of Group A Strep (GAS) antigens from throat swabs. The purpose of the study is to evaluate the clinical performance of the investigational device (i.e., sensitivity, specificity, NPV and PPV) when used by untrained lay persons to detect the presence of Group A Streptococcal antigens in throat swab specimens from individuals five years of age and older with signs and symptoms of pharyngitis, such as fever and sore throat.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Streptococcus Pyogenes Infection Bacterial Infections Bacterial Infections and Mycoses Gram-Positive Bacterial Infections Infections Otorhinolaryngologic Diseases Pharyngeal Diseases Pharyngitis Respiratory Tract Diseases Respiratory Tract Infections Stomatognathic Diseases Streptococcal Infections

Age range

5 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Robertson Pediatrics, Beverly Hills, California, United States

About this study

The study is a prospective, consecutive, non-interventional multicenter study to evaluate the clinical performance of the Checkable Medical At-Home Strep A Test when the test is performed by non-trained adult lay users.

Patients or parents/legal guardians of patients presenting with signs and symptoms of pharyngeal GAS infections will be recruited at primary care or urgent care clinics.
Informed consent will be obtained from adult subjects and from the parents/guardians of pediatric subjects. Pediatric subjects 7 years of age or greater will be asked for their assent.
The lay user will be provided with a Checkable Medical At-Home Strep A Test kit. The user and patient will be provided with a quiet, private space where the user can collect the throat swab specimen and perform the investigational test.
Once the lay user has collected the swab sample for the Checkable Medical At-Home Strep A Test and performed the test, she/he will document the test result. The Checkable Medical At-Home Strep A Test result is not to be shared with members of the site team who are providing healthcare to the subject.
When all sample collection, testing and interpretation activities related to the investigational test are completed, a healthcare provider at the study site will collect two additional swab samples. One of these samples will be sent to a central lab where it will be cultured for GAS. An additional sample will be tested using the organization's standard of care (SOC) rapid Strep A test.
Subjects will be diagnosed and treated in accordance with routine SOC which may include an FDA-cleared rapid GAS test. The Checkable Medical At-Home Strep A Test will not be used to diagnose or treat study subjects.
This study will take place in at least six sites in at least three different regions of the United States.
The results from the Checkable Medical At-Home Strep A Test will be used to compare with the diagnostic truth obtained through culture to compute diagnostic accuracy parameters including sensitivity, NPV, specificity and PPV.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects seeking medical care for two or more of the following signs/symptoms of pharyngeal streptococcal infections:

pharyngeal pain [with or without swallowing],
tonsillar swelling with exudates,
pharyngeal erythema,
tender cervical lymphadenopathy,
fever.
Subjects who have not received antibiotic treatment within the past 14 days.
Subjects (or their parents/guardians) provide written informed consent/assent to participate in the study

Exclusion criteria

Lay users who are accompanying patients are unwilling/unable to collect throat swab sample from a child or adult.

Treatment and study plan

untrained lay user performs investigational diagnostic test

Diagnostic Test

Untrained lay users (parents/guardians of pediatric subjects or friends/family members of adult subjects) collect throat swab specimens and perform the investigational diagnostic test.

Primary outcomes

Clinical Sensitivity and Clinical Specificity

Time frame: 1 day

Sensitivity is the proportion of subjects with a positive bacterial culture that are also positive in the investigational Strep A test (+).

Specificity is the proportion of subjects with a negative bacterial culture that are also negative in the investigational Strep A test (-).

Secondary outcomes

Negative Predictive Value

Time frame: 1 day

Negative Predictive Value (NPV) is the proportion of subjects with negative investigational Strep A test results who also have negative cultures (diagnostic truth); calculated as 100 x d/(c+d).

Sponsors and collaborators

Lead sponsor

Checkable Medical Inc

Industry

Collaborators

Curebase Inc.

Registry information

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Nov 4, 2021
Registry last updated: Jul 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed